SEI Investments’s Maravai LifeSciences MRVI Stock Holding History

SEI Investments’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$870K	Buy	+139,455	New	+$602K	﹤0.01%	2373
2025 Q1	–	Sell	-32,659	Closed	-$178K	–	2808
2024 Q4	$178K	Sell	32,659 -10,368	-24%	-$66.7K	﹤0.01%	2496
2024 Q3	$358K	Buy	43,027 +22,357	+108%	+$193K	﹤0.01%	2291
2024 Q2	$148K	Sell	20,670 -45,593	-69%	-$394K	﹤0.01%	2493
2024 Q1	$574K	Sell	66,263 -3,643	-5%	-$24.6K	﹤0.01%	2067
2023 Q4	$458K	Sell	69,906 -47,711	-41%	-$308K	﹤0.01%	2140
2023 Q3	$1.18M	Buy	117,617 +23,584	+25%	+$259K	﹤0.01%	1833
2023 Q2	$1.17M	Sell	94,033 -19,517	-17%	-$263K	﹤0.01%	1833
2023 Q1	$1.59M	Buy	113,550 +37,813	+50%	+$543K	﹤0.01%	1716
2022 Q4	$1.08M	Buy	75,737 +8,662	+13%	+$136K	﹤0.01%	1726
2022 Q3	$1.71M	Sell	67,075 -103,695	-61%	-$2.6M	﹤0.01%	1611
2022 Q2	$4.74M	Buy	170,770 +11,541	+7%	+$366K	0.01%	1123
2022 Q1	$5.55M	Buy	159,229 +11,079	+7%	+$371K	0.01%	1047
2021 Q4	$6.19M	Sell	148,150 -1,995	-1%	-$80.8K	0.01%	1019
2021 Q3	$7.35M	Sell	150,145 -113,259	-43%	-$5.52M	0.02%	906
2021 Q2	$11M	Buy	263,404 +169,101	+179%	+$6.55M	0.02%	679
2021 Q1	$3.06M	Buy	94,303 +61,029	+183%	+$2.02M	0.01%	1268
2020 Q4	$831K	Buy	+33,274	New	+$927K	﹤0.01%	1764

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

SEI Investments's MRVI Position: Q2 2026 in Review

SEI Investments opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 139,455 shares worth $870K. The stake represents ﹤0.01% of the portfolio and ranks #2373 among its holdings. This is a return to the name: SEI Investments previously reported a position in MRVI as recently as Q4 2024.

SEI Investments first reported a position in MRVI in Q4 2020 and has held it in 18 quarters since. The position peaked at $11M in Q2 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

SEI Investments held 139,455 shares of Maravai LifeSciences worth $870K as of Q2 2026.
Maravai LifeSciences was a new SEI Investments position in Q2 2026.
Maravai LifeSciences made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2373 holding.
SEI Investments first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 18 quarters since.
SEI Investments's Maravai LifeSciences position peaked at $11M in Q2 2021.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.